‌

US Patent 11834421 Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof

Patent 11834421 was granted and assigned to Japan Tobacco on December, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Masahiro Yokota0

Shingo Fujioka0

Noriyoshi Seki0

Eiichi Watanabe0

Date of Patent

December 5, 2023

0

Patent Application Number

173345170

Date Filed

May 28, 2021

0

Patent Citations

US Patent 9198917 Hexahydropyrano[3,4-

0

US Patent 9266886 Dihydropyrrolopyridine inhibitors of ROR-gamma

0

US Patent 9624217 Dihydropyrrolopyridine inhibitors of ROR-gamma

0

US Patent 10047085 Dihydropyrrolopyridine inhibitors of ROR-gamma

0

US Patent 10047098 C5-C6-oxacyclic fused iminopyrimidinone compounds as bace inhibitors, compositions, and their use

0

US Patent 10196363 Dihydropyrimidin-2-one compounds and medical use thereof

0

US Patent 10399976 Dihydropyrrolopyridine inhibitors of ROR-gamma

0

US Patent 10807980 Dihydropyrrolopyridine inhibitors of ROR-gamma

0

...

Patent Primary Examiner

Brenda L Coleman

0

CPC Code

0

0

0

0

0

0

0

0

...

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11834421 Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.